Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases, Papulosquamous

Explore clinical trials studying Skin Diseases, Papulosquamous. Study availability and eligibility vary by location and protocol.

1,740 public trials 205 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases, Papulosquamous trial results

Completed

24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis

NCT01989468

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +11 more
Locations
  • Novartis Investigative Site Aventura, Florida, United States
  • Novartis Investigative Site Palm Harbor, Florida, United States
  • Novartis Investigative Site Sarasota, Florida, United States
  • Novartis Investigative Site Indianapolis, Indiana, United States
View all 77 locations
View Trial Details
Completed

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis

NCT01815424

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +25 more
Locations
  • Dept. Of dermatology &STD, Beijing Friendship Hospital, Capital Medical University Xicheng District, Beijing Municipality, China
  • Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University Guangzhou, Guangdong, China
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
View all 24 locations
View Trial Details
Completed

An Efficacy and Safety Study of LYC-30937-EC in Subjects With Moderate Chronic Plaque-type Psoriasis

NCT02872285

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Lycera Investigational Site Carmel, Indiana, United States
  • Lycera Investigational Site Andover, Massachusetts, United States
  • Lycera Investigational Site Fridley, Minnesota, United States
  • Lycera Investigational Site East Windsor, New Jersey, United States
View Trial Details
Completed

Secukinumab in Tumor Necrosis Factor (TNF) - Inadequate Response (IR) Psoriasis Participants.

NCT01961609

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Novartis Investigative Site Cork, Ireland
  • Novartis Investigative Site Dublin, Ireland
  • Novartis Investigative Site Dublin, Ireland
  • Novartis Investigative Site Plymouth, Devon, United Kingdom
View all 54 locations
View Trial Details
Completed

Study to Assess the Efficacy, Safety and Tolerability of Secukinumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)

NCT01952015

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Novartis Investigative Site Fukuoka, Japan
  • Novartis Investigative Site Kitakyushu, Fukuoka, Japan
  • Novartis Investigative Site Asahikawa, Hokkaido, Japan
  • Novartis Investigative Site Sapporo, Hokkaido, Japan
View Trial Details

Related conditions